Cannon Gillian
SEC insider (Form 3/4/5 filer). CIK 0001833910. Director at Xenon Pharmaceuticals Inc. (XENE) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in BURNABY.
Companies Cannon Gillian has filed insider reports for
- Xenon Pharmaceuticals Inc. (XENE): Director
- CORCEPT THERAPEUTICS INC (CORT): Director
Cannon Gillian
CIK: 0001833910
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 5, 2026XENE
Xenon Pharmaceuticals Inc.
SaleDirect1.2K shares at avg. $53.14$63K - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectRestricted Share Units
1.6K shares- - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectShare Option (Right to Buy)
10.5K shares- - Jun 1, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect2.6K shares- - Sep 10, 2025CORT
CORCEPT THERAPEUTICS INC
GiftDirect7.4K shares- - Sep 4, 2025CORT
CORCEPT THERAPEUTICS INC
ExerciseDirect11K shares at avg. $22.99$253K - Sep 4, 2025CORT
CORCEPT THERAPEUTICS INC
Tax PaymentDirect3.6K shares at avg. $70.13$253K - Jun 10, 2025CORT
CORCEPT THERAPEUTICS INC
AwardDirectStock option (right to buy)
15K shares- - Jun 5, 2025XENE
Xenon Pharmaceuticals Inc.
AwardDirectRestricted Share Units
2.6K shares- - Jun 5, 2025XENE
Xenon Pharmaceuticals Inc.
AwardDirectShare Option (Right to Buy)
17K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  XENE Xenon Pharmaceuticals Inc. | Sale | 1,190 | $53.14 | $63,237 | Direct |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | Award Restricted Share Units | 1,593 | - | - | Direct |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | Award Share Option (Right to Buy) | 10,507 | - | - | Direct |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc. | Exercise | 2,645 | - | $0 | Direct |
| Sep 10, 2025 |  CORT CORCEPT THERAPEUTICS INC | Gift | 7,393 | - | - | Direct |
| Sep 4, 2025 | CORT CORCEPT THERAPEUTICS INC | Exercise | 11,000 | $22.99 | $252,890 | Direct |
| Sep 4, 2025 | CORT CORCEPT THERAPEUTICS INC | Tax Payment | 3,607 | $70.13 | $252,959 | Direct |
| Jun 10, 2025 | CORT CORCEPT THERAPEUTICS INC | Award Stock option (right to buy) | 15,000 | - | - | Direct |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | Award Restricted Share Units | 2,645 | - | - | Direct |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | Award Share Option (Right to Buy) | 17,012 | - | - | Direct |
1-10 of 10 transactions